Christopher Astle

ZYME

Christopher Astle serves as SVP & Chief Financial Officer at Zymeworks Inc. (ZYME). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$78.1K

Net Position

Net Seller

$78.1K

Companies Traded

ZYME

Active Period

Dec 2022 – Jan 2024

3 total trades

Most Recent

Sell ZYME

Jan 8, 2024 · $64.7K

Christopher Astle's Insider Trading at Zymeworks Inc. (ZYME)

Buys

0 · $0.00

Sells

3 · $78.1K

Total Shares Bought

Total Shares Sold

7,767

ZYME Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 8, 2024	Sell	5,994	$10.79	$64.7K	7,934
Dec 11, 2023	Sell	886	$9.13	$8.1K	1,997
Dec 14, 2022	Sell	887	$6.01	$5.3K	1,333

Related Insiders

Adam Schayowitz

officer: EVP, Head of R&D

ZYMESell · Oct 9, 2026

Mark Hollywood

officer: EVP & Chief Operating Officer

ZYMESell · Jan 13, 2026

Kenneth Galbraith

director, officer: Chair & CEO

ZYMESell · Jan 12, 2026

Paul Andrew Moore

officer: Chief Scientific Officer

ZYMESell · Jan 12, 2026

Jeffrey T L Smith

officer: EVP & Chief Medical Officer

ZYMESell · Jan 12, 2026

Explore More Insider Trading Data

ZYME Insider Trading Activity

View all insider trades at Zymeworks Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity